| 02:40a | Sareum Holdings Says GSK Completes Acquisition of Sierra Oncology | DJ |
| 07/03 | UBS Joins Investors To Deliver $1 Billion Research Site In UK For GSK | MT |
| 07/01 | GSK completes acquisition of Sierra Oncology | AQ |
| 07/01 | GSK Completes $1.9 Billion Purchase of Sierra Oncology | MT |
| 07/01 | GSK : completes acquisition of Sierra Oncology - Form 6-K | PU |
| 07/01 | GLAXOSMITHKLINE : Credit Suisse maintains a Sell rating | MD |
| 07/01 | Pharmaceutical companies still have the upper hand | |
| 06/29 | Sierra Oncology Shareholders Approve Acquisition by GSK | MT |
| 06/29 | GSK Selects Target the Future Grant Recipient in Innovation Challenge Supporting Multip.. | BU |
| 06/29 | FTSE 100 retreats from two-week high on slowdown worries | RE |
| 06/29 | GLAXOSMITHKLINE : JP Morgan sticks Neutral | MD |
| 06/28 | GlaxoSmithKline Files for Expanded Use of Shingrix Shingles Vaccine in Japan | MT |
| 06/28 | Japan's Ministry of Health, Labour and Welfare accepts Shingrix regulatory submission t.. | AQ |
| 06/28 | GSK Seeks Japanese Regulatory Approval For Shingles Vaccine In Adults Over 18 Years | MT |
| 06/28 | GSK plc Announces the Submission of A Regulatory Application to the Japanese Ministry o.. | CI |
| 06/28 | GSK Submits Shingrix Regulatory Application in Japan for Adults 18 and Older | DJ |
| 06/27 | GSK's Haleon Selects Citigroup, UBS Group of Planned Spinoff on London Bourse | MT |
| 06/27 | GSK Says Antiviral Drug Lowered Hepatitis B Surface Antigen in Phase 2b Trial | MT |
| 06/27 | GSK presents promising new data for bepirovirsen, an investigational treatment for chro.. | AQ |
| 06/26 | GSK's Investigational Hepatitis B Drug Shows Potential as Functional Cure in Phase 2b S.. | MT |
| 06/25 | GSK : presents promising new data for bepirovirsen, an investigational treatment for chron.. | PU |
| 06/25 | Promising hep B data helps GSK inch closer to functional cure | RE |
| 06/24 | European Stocks Join Global Rally, Closes Week in the Green | MT |
| 06/24 | SECTOR UPDATE : Health Care Stocks Edge Higher Premarket Friday | MT |
| 06/24 | European shares mark strong end to nervous week | RE |
| 06/24 | Sanofi, GSK variant-specific COVID shot found effective against Omicron | RE |
| 06/24 | Sanofi, GSK COVID-19 Bivalent Vaccine Candidate Shows 72% Efficacy Against Omicron in P.. | MT |
| 06/24 | Sanofi, GSK Target COVID-19 Vaccine Availability in Late-2022 After New Positive Late-s.. | MT |
| 06/24 | Sanofi-GSK's COVID-19 Jab 72% Effective Against Omicron Variant in Late-stage Study | MT |
| 06/24 | Sanofi says COVID-19 vaccine candidate yields positive trial data | RE |
| 06/24 | GSK : Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19.. | PU |
| 06/24 | GSK Says Sanofi-GSK First To Report Successful Efficacy Study Against Omicron With COVI.. | RE |
| 06/24 | Sanofi, GSK Report Successful Vaccine Study Against Omicron | DJ |
| 06/23 | Oragenics Appoints Kimberly Murphy as President, CEO | MT |
| 06/23 | GSK Announces £1 Billion R&D Investment over Ten Years to Get Ahead of Infectious Disea.. | CI |
| 06/23 | GSK to Invest $1.22 Billion in Infectious Disease Research for Lower-Income Countries | MT |
| 06/23 | GSK to Invest GBP1 Billion Tackling Infectious Diseases in Low-Income Countries | DJ |
| 06/23 | Viridian Therapeutics Appoints Carrie Melvin to Fill New COO Role | MT |
| 06/23 | GSK Unveils $1.22 Billion R&D Investment Plan for Infectious Diseases | MT |
| 06/23 | Viridian Therapeutics Appoints Carrie Melvin as Chief Operating Officer | AQ |
| 06/23 | GSK Announces £1 Billion Research And Development Investment | RE |
| 06/23 | GSK : announces £1 billion R&D investment over ten years to get ahead of infectious diseas.. | PU |
| 06/23 | GSK, Novartis pledge funds for diseases that mostly affect the poor | RE |
| 06/23 | GLAXOSMITHKLINE : Jefferies reaffirms its Buy rating | MD |
| 06/22 | Fitch Maintains, Withdraws GSK Ratings for Commercial Reasons | MT |
| 06/15 | GSK Spinoff Haleon to Debut in London on July 18, FTSE Russell Confirms | MT |
| 06/15 | FTSE Russell Says Haleon Will Be Added To All Same Indices As GSK On July 18 | RE |
| 06/15 | GSK to Present New Data from the B-Clear Phase IIb Trial for Bepirovirsen in Chronic He.. | CI |
| 06/15 | GSK : to present new data from the B-Clear phase IIb trial for bepirovirsen in chronic hep.. | PU |
| 06/14 | TRANSCRIPT : GSK plc Presents at 19th annual dbAccess Global Consumer Conference 2022, Jun.. | CI |
| 06/14 | FTSE 100 falls for six straight sessions on rising rate-hike bets | RE |
| 06/13 | TRANSCRIPT : GSK plc Presents at Goldman Sachs 43rd Annual Global Healthcare Conference, J.. | CI |
| 06/13 | GLAXOSMITHKLINE : Gets a Neutral rating from Deutsche Bank | MD |
| 06/13 | Sanofi, GSK COVID-19 Booster Injection Shows Strong Immune Response Against Omicron, Ot.. | MT |
| 06/13 | Sanofi says next-gen COVID booster shot has potential against main variants | RE |
| 06/13 | Sanofi-GSK Says COVID-19 Booster Provides Stronger Protection Against Omicron, Other Va.. | MT |
| 06/13 | CORRECTION : Sanofi-GSK COVID-19 Booster Jab Shows Strong Immune Response Against Multiple.. | MT |
| 06/13 | Sanofi-GSK COVID-19 Booster Jab Shows Strong Immune Response Against Multiple Variants .. | MT |
| 06/13 | Sanofi-GSK Covid-19 Booster Showing Strong Immune Response, Sanofi Says | DJ |
| 06/10 | European Bourses Plunge Friday on Gloomy Economic Outlook, Inflation Fears | MT |
| 06/10 | European ADRs Tumble in Friday Trading | MT |
| 06/10 | GSK Says Vaccine Candidate Against Respiratory Syncytial Virus Showed 'Clinically Meani.. | MT |
| 06/10 | GLAXOSMITHKLINE : UBS gives a Neutral rating | MD |
| 06/10 | GSK announces positive pivotal phase III data for its respiratory syncytial virus (RSV).. | AQ |
| 06/10 | GLAXOSMITHKLINE : Berenberg gives a Buy rating | MD |
| 06/10 | GLAXOSMITHKLINE : JP Morgan reiterates its Neutral rating | MD |
| 06/10 | GSK's Respiratory Syncytial Virus Jab Shows Potential In Providing 'Exceptional' Protec.. | MT |
| 06/10 | LONDON STOCK EXCHANGE : Miners drag UK'S FTSE 100 lower after hawkish ECB; GSK rises | RE |
| 06/10 | EUROPE : European shares slip ahead of U.S. inflation data | RE |
| 06/10 | GSK's Respiratory Syncytial Virus Vaccine Candidate Shows Meaningful Efficacy in Older .. | MT |
| 06/10 | GSK Reports Positive Phase III Data For RSV Vaccine Candidate | RE |
| 06/10 | GSK plc Announces Positive Headline Results from A Pre-Specified Efficacy Interim Analy.. | CI |
| 06/10 | GSK Says RSV Vaccine Candidate Showed Significant Efficacy in Phase 3 Trial | DJ |
| 06/08 | SOCIAL BUZZ : Wallstreetbets Stocks Largely Down Premarket; GameStop, Target Poised to Fal.. | MT |
| 06/07 | MARKETSCREENER'S WORLD PRESS REVIEW : June 6, 2022 | |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
